172 related articles for article (PubMed ID: 28357632)
1. Radiotherapy for adrenal gland metastases from hepatocellular carcinoma.
Yuan BY; Hu Y; Zhang L; Chen YH; Dong YY; Zeng ZC
Clin Transl Oncol; 2017 Sep; 19(9):1154-1160. PubMed ID: 28357632
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors.
Zhou LY; Zeng ZC; Fan J; Chen B; Rao SX; He J; Yang P; Hou JZ; Wu ZF; Zhang JY; Hu Y
BMC Cancer; 2014 Nov; 14():878. PubMed ID: 25421498
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for adrenal gland metastases from hepatocellular carcinoma.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Zhang JY; Yu Y; Cheng JM; Wang XL; Guo W
Jpn J Clin Oncol; 2005 Feb; 35(2):61-7. PubMed ID: 15709088
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 13-05).
Jung J; Yoon SM; Park HC; Nam TK; Seong J; Chie EK; Kim TH; Kim MS; Kim CY; Jang HS; Kim JH
PLoS One; 2016; 11(3):e0152642. PubMed ID: 27022932
[TBL] [Abstract][Full Text] [Related]
6. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
7. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma.
Huang CM; Huang MY; Tang JY; Chen SC; Wang LY; Lin ZY; Huang CJ
World J Surg Oncol; 2015 Jun; 13():201. PubMed ID: 26072055
[TBL] [Abstract][Full Text] [Related]
9. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
[TBL] [Abstract][Full Text] [Related]
10. Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy.
Son SH; Park EY; Park HH; Kay CS; Jang HS
Oncotarget; 2017 Mar; 8(10):16964-16971. PubMed ID: 28199977
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous multitarget radiotherapy using helical tomotherapy and its combination with sorafenib for pulmonary metastases from hepatocellular carcinoma.
Sun T; He J; Zhang S; Sun J; Zeng M; Zeng Z
Oncotarget; 2016 Jul; 7(30):48586-48599. PubMed ID: 27191894
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
14. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
15. Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma.
Yoon HI; Lee IJ; Han KH; Seong J
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1595-605. PubMed ID: 24809934
[TBL] [Abstract][Full Text] [Related]
16. Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma.
Lee DY; Park JW; Kim TH; Lee JH; Kim BH; Woo SM; Kim SS; Lee WJ; Kim DY; Kim CM
Strahlenther Onkol; 2015 Nov; 191(11):835-44. PubMed ID: 26174506
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
Chance WW; Nguyen QN; Mehran R; Welsh JW; Gomez DR; Balter P; Komaki R; Liao Z; Chang JY
Pract Radiat Oncol; 2017; 7(3):e195-e203. PubMed ID: 27743801
[TBL] [Abstract][Full Text] [Related]
18. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
[TBL] [Abstract][Full Text] [Related]
19. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma.
Kato H; Yoshida H; Taniguch H; Nomura R; Sato K; Suzuki I; Nakata R
World J Gastroenterol; 2015 Dec; 21(46):13101-12. PubMed ID: 26673627
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
